首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   116301篇
  免费   13689篇
  国内免费   413篇
  130403篇
  2021年   853篇
  2018年   1150篇
  2017年   1070篇
  2016年   1470篇
  2015年   1879篇
  2014年   2322篇
  2013年   2888篇
  2012年   3409篇
  2011年   3284篇
  2010年   2236篇
  2009年   2146篇
  2008年   2735篇
  2007年   2720篇
  2006年   2658篇
  2005年   2416篇
  2004年   2401篇
  2003年   2342篇
  2002年   2281篇
  2001年   9689篇
  2000年   9551篇
  1999年   7240篇
  1998年   1662篇
  1997年   1812篇
  1996年   1604篇
  1995年   1423篇
  1994年   1318篇
  1993年   1263篇
  1992年   4809篇
  1991年   4541篇
  1990年   4000篇
  1989年   4028篇
  1988年   3615篇
  1987年   3087篇
  1986年   2783篇
  1985年   2685篇
  1984年   1981篇
  1983年   1732篇
  1982年   1232篇
  1981年   986篇
  1980年   917篇
  1979年   1767篇
  1978年   1366篇
  1977年   1204篇
  1976年   1030篇
  1975年   1157篇
  1974年   1171篇
  1973年   1164篇
  1972年   1035篇
  1971年   955篇
  1970年   823篇
排序方式: 共有10000条查询结果,搜索用时 7 毫秒
311.
312.
313.
314.
315.
Binding of HIV to its receptor, the CD4 molecule of lymphocytes, can be prevented by chemical agents. These agents could be considered as potential anti-AIDS drugs. We have shown that aurin tricarboxylic acid (ATA, 3 microM) specifically blocks the binding of gp120, the HIV coat protein, to the CD4 molecule. We have also found that ATA prevents the binding of interferon-alpha to its receptor in a dose-dependent manner (12-50 microM range). Membrane potential shift, associated with binding of interferon-alpha to its receptor, was also blocked by ATA in a dose-dependent fashion. Our results indicate that potential anti-AIDS drugs should be screened for such undesired side effects.  相似文献   
316.
Comparative sequence analysis of Escherichia coli ATP-dependent La protease led to the suggestion that Ser679 is the catalytically active enzyme residue. Site-directed mutagenesis Ser679----Ala, investigation of the cells containing the mutant plasmid, and study of the partially purified mutant protein produced results in favour of this suggestion.  相似文献   
317.
318.
After periodate oxidation and incubation with a dihydrazide, cross-linking of the two heavy chains of immunoglobulins G from several species proceeds specifically through their oligosaccharides. We have used malonic acid dihydrazide, adipic acid dihydrazide and dithiodipropionic acid dihydrazide. The last compound is introduced in this work as a cleavable-carbohydrate-specific cross-linker. It was found that in rabbit and human immunoglobulins the degree of cross-linking was strongly dependent on the oxidation conditions but only very weakly dependent on the concentration and size of the dihydrazides. Papain cleavage of the cross-linked rabbit IgG indicated that the cross-linking occurred predominantly, if not exclusively, in the Fc region, probably through the two glycans linked to Asn-297 in the CH2 domain of each of the two heavy chains. The immunoglobulins from sheep, pig, goat and guinea pig show a comparable cross-linking pattern, indicating that the sugar chains from these immunoglobulins have a spatial structure closely related to that of rabbit and human IgG. When dithiodipropionic acid dihydrazide was used as the cross-linker, the cross-link could be cleaved by mercaptoethanol.  相似文献   
319.
320.
The alpha-toxin (phospholipase C) of Clostridium perfringens has been reported to contain catalytically essential zinc ions. We report here that histidine residues are essential for the co-ordination of these ion(s). Incubation of alpha toxin with diethylpyrocarbonate, a histidine modifying reagent, did not result in the loss of phospholipase C activity unless the protein was first incubated with EDTA, suggesting that zinc ions normally protect the susceptible histidine residues. When the amino acid sequences of three phospholipase C's were aligned, essential zinc binding histidine residues in the non-toxic B. cereus phospholipase C were found in similar positions in the toxic C. perfringens enzyme and the weakly toxic C. bifermentans phospholipase C.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号